DFTX

Definium Therapeutics, Inc. Common Shares
DFTX

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$35
135% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Jones Trading
Jones Trading
Justin Walsh
100% 1-yr DFTX win rate
23 Dec ‘25 25 days ago
Canaccord Genuity
Canaccord Genuity
Sumant Kulkarni
100% 1-yr DFTX win rate
7 Nov ‘25 2 months ago
RBC Capital
RBC Capital
Brian Abrahams
100% 1-yr DFTX win rate
7 Nov ‘25 2 months ago